Published in J Clin Invest on April 01, 1993
Epigallocatechin-3-gallate suppresses the global interleukin-1beta-induced inflammatory response in human chondrocytes. Arthritis Res Ther (2011) 1.08
Interleukin 1 beta suppresses transforming growth factor-induced inorganic pyrophosphate (PPi) production and expression of the PPi-generating enzyme PC-1 in human chondrocytes. Proc Natl Acad Sci U S A (1995) 1.04
Scientific evidence and rationale for the development of curcumin and resveratrol as nutraceutricals for joint health. Int J Mol Sci (2012) 0.90
Identification of secreted proteins that reflect autophagy dynamics within tumor cells. Autophagy (2015) 0.88
A Key Role for Leukemia Inhibitory Factor in C26 Cancer Cachexia. J Biol Chem (2015) 0.86
Extensive mannose phosphorylation on leukemia inhibitory factor (LIF) controls its extracellular levels by multiple mechanisms. J Biol Chem (2011) 0.84
Upregulation of chemokine (C-C motif) ligand 20 in adult epidermal keratinocytes in direct current electric fields. Arch Dermatol Res (2009) 0.81
Anti-inflammatory strategies in cartilage repair. Tissue Eng Part B Rev (2014) 0.78
Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem (1987) 281.19
Myeloid leukaemia inhibitory factor maintains the developmental potential of embryonic stem cells. Nature (1988) 13.21
Inhibition of pluripotential embryonic stem cell differentiation by purified polypeptides. Nature (1988) 7.61
Buffalo rat liver cells produce a diffusible activity which inhibits the differentiation of murine embryonal carcinoma and embryonic stem cells. Dev Biol (1987) 5.96
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A (1981) 4.89
The IL-6 signal transducer, gp130: an oncostatin M receptor and affinity converter for the LIF receptor. Science (1992) 3.64
Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest (1989) 2.83
Leukemia inhibitory factor receptor is structurally related to the IL-6 signal transducer, gp130. EMBO J (1991) 2.56
The cholinergic neuronal differentiation factor from heart cells is identical to leukemia inhibitory factor. Science (1989) 2.23
Resolution and purification of three distinct factors produced by Krebs ascites cells which have differentiation-inducing activity on murine myeloid leukemic cell lines. J Biol Chem (1988) 2.05
Hepatocyte-stimulating factor III shares structural and functional identity with leukemia-inhibitory factor. J Immunol (1989) 1.87
IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol (1990) 1.82
Purification of a factor inducing differentiation of mouse myeloid leukemic M1 cells from conditioned medium of mouse fibroblast L929 cells. J Biol Chem (1984) 1.69
Fatal syndrome in mice engrafted with cells producing high levels of the leukemia inhibitory factor. Proc Natl Acad Sci U S A (1989) 1.66
Oncostatin M is a member of a cytokine family that includes leukemia-inhibitory factor, granulocyte colony-stimulating factor, and interleukin 6. Proc Natl Acad Sci U S A (1991) 1.60
Specific binding of murine leukemia inhibitory factor to normal and leukemic monocytic cells. Proc Natl Acad Sci U S A (1988) 1.60
Leukemia inhibitory factor and interleukin-6 trigger the same immediate early response, including tyrosine phosphorylation, upon induction of myeloid leukemia differentiation. Mol Cell Biol (1991) 1.58
Interleukin-6 induces the synthesis of tissue inhibitor of metalloproteinases-1/erythroid potentiating activity (TIMP-1/EPA). J Biol Chem (1991) 1.58
Cartilage and joint inflammation. Regulation of IL-8 expression by human articular chondrocytes. J Immunol (1992) 1.36
Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest (1992) 1.20
Generation of sensory neurons is stimulated by leukemia inhibitory factor. Proc Natl Acad Sci U S A (1991) 1.14
Leukemia inhibitory factor differentiation-inhibiting activity/human interleukin for DA cells augments proliferation of human hematopoietic stem cells. Blood (1990) 1.12
Differentiation-inducing factor purified from conditioned medium of mitogen-treated spleen cell cultures stimulates bone resorption. Proc Natl Acad Sci U S A (1986) 1.10
Actions and interactions of G-CSF, LIF, and IL-6 on normal and leukemic murine cells. Leukemia (1989) 1.10
Leukemia inhibitory factor: a novel bone-active cytokine. Endocrinology (1990) 1.05
Leukemia inhibitory factor is expressed in cartilage and synovium and can contribute to the pathogenesis of arthritis. J Clin Invest (1992) 1.04
Purification of a lipoprotein lipase-inhibiting protein produced by a melanoma cell line associated with cancer cachexia. Biochem Biophys Res Commun (1989) 1.02
The pleiotropic actions of leukemia inhibitory factor. Cancer Cells (1989) 0.94
Cytokine regulation of substance P expression in sympathetic neurons. Proc Natl Acad Sci U S A (1991) 0.93
A factor produced by feeder cells which inhibits embryonal carcinoma cell differentiation. Characterization and partial purification. Exp Cell Res (1984) 0.85
Production of human interleukin for DA cells (HILDA)/leukemia inhibitory factor (LIF) by activated monocytes. Cell Immunol (1990) 0.84
Constitutive production of human interleukin for DA cells/leukemia inhibitory factor by human tumor cell lines derived from various tissues. J Immunol (1990) 0.83
Expression of leukemia inhibitory factor is regulated in human mesenchymal cells. Leukemia (1991) 0.83
Biochemical characterization and purification of HILDA, a human lymphokine active on eosinophils and bone marrow cells. Blood (1988) 0.83
Localization of cholinergic differentiation factor/leukemia inhibitory factor mRNA in the rat brain and peripheral tissues. Proc Natl Acad Sci U S A (1991) 0.79
Effects of interleukin-6 and leukemia inhibitory factor on the acute phase response and DNA synthesis in cultured rat hepatocytes. Lymphokine Cytokine Res (1991) 0.79
Specific protection against breast cancers by cyclin D1 ablation. Nature (2001) 6.94
The molecular basis of muscular dystrophy in the mdx mouse: a point mutation. Science (1989) 6.80
Cyclin D2 is an FSH-responsive gene involved in gonadal cell proliferation and oncogenesis. Nature (1996) 4.05
Immunostimulatory DNA sequences necessary for effective intradermal gene immunization. Science (1996) 3.82
Evidence for a phosphorus-depletion syndrome in man. N Engl J Med (1968) 3.34
Cytokines in symptomatic asthma airways. J Allergy Clin Immunol (1992) 3.01
Bacterial lipopolysaccharide and inflammatory mediators augment IL-6 secretion by human endothelial cells. J Immunol (1989) 3.01
E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc Natl Acad Sci U S A (1995) 2.99
Synovium as a source of interleukin 6 in vitro. Contribution to local and systemic manifestations of arthritis. J Clin Invest (1989) 2.83
Interleukin-17-induced gene expression in articular chondrocytes is associated with activation of mitogen-activated protein kinases and NF-kappaB. J Biol Chem (1998) 2.43
Linkage of chondrocyte apoptosis and cartilage degradation in human osteoarthritis. Arthritis Rheum (1998) 2.19
Chondrocyte apoptosis induced by nitric oxide. Am J Pathol (1995) 2.16
Substance P activation of rheumatoid synoviocytes: neural pathway in pathogenesis of arthritis. Science (1987) 1.97
Cell death in cartilage. Osteoarthritis Cartilage (2004) 1.94
A new set of chemotaxis homologues is essential for Myxococcus xanthus social motility. Mol Microbiol (1998) 1.91
Production of the chemokine RANTES by articular chondrocytes and role in cartilage degradation. Arthritis Rheum (2001) 1.85
IL-6 production by human articular chondrocytes. Modulation of its synthesis by cytokines, growth factors, and hormones in vitro. J Immunol (1990) 1.82
Production of monocyte chemoattractant protein-1 by inflamed synovial tissue and cultured synoviocytes. J Immunol (1992) 1.72
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med (1998) 1.69
Castleman's disease in POEMS syndrome with elevated interleukin-6. Cancer (1992) 1.59
IL-18 is produced by articular chondrocytes and induces proinflammatory and catabolic responses. J Immunol (1999) 1.59
Identification of a cellular protein that interacts and synergizes with the RTA (ORF50) protein of Kaposi's sarcoma-associated herpesvirus in transcriptional activation. J Virol (2001) 1.58
Filamin A mutations cause periventricular heterotopia with Ehlers-Danlos syndrome. Neurology (2005) 1.57
Transforming growth factor beta and noncytopathic mechanisms of immunodeficiency in human immunodeficiency virus infection. Proc Natl Acad Sci U S A (1990) 1.55
Regulation of Epstein-Barr virus infection by recombinant interferons. Selected sensitivity to interferon-gamma. Eur J Immunol (1985) 1.55
Activation of resting T lymphocytes by anti-CD3 (T3) antibodies in the absence of monocytes. J Immunol (1985) 1.53
Chondrocyte apoptosis and nitric oxide production during experimentally induced osteoarthritis. Arthritis Rheum (1998) 1.52
Protein tyrosine kinase activation is required for lipopolysaccharide induction of cytokines in human blood monocytes. J Immunol (1993) 1.50
Overexpression of pp60c-src elicits invasive behavior in rat colon epithelial cells. Gastroenterology (1998) 1.49
Basis for defective responses of rheumatoid arthritis synovial fluid lymphocytes to anti-CD3 (T3) antibodies. J Clin Invest (1986) 1.46
Cytokine regulation of chondrocyte functions. J Rheumatol Suppl (1995) 1.45
Selective activation of the mitogen-activated protein kinase subgroups c-Jun NH2 terminal kinase and p38 by IL-1 and TNF in human articular chondrocytes. J Clin Invest (1996) 1.44
[Quality assurance in clinical social work: how do social workers judge the success of their interventions?]. Psychiatr Prax (1996) 1.39
Timing of cyclin E gene expression depends on the regulated association of a bipartite repressor element with a novel E2F complex. EMBO J (1999) 1.39
ILA, the human 4-1BB homologue, is inducible in lymphoid and other cell lineages. Blood (1995) 1.33
Growth factor responsiveness of human articular chondrocytes: distinct profiles in primary chondrocytes, subcultured chondrocytes, and fibroblasts. J Cell Physiol (1994) 1.33
Chondrocyte-derived apoptotic bodies and calcification of articular cartilage. Proc Natl Acad Sci U S A (1998) 1.33
Up-regulated expression of the phosphodiesterase nucleotide pyrophosphatase family member PC-1 is a marker and pathogenic factor for knee meniscal cartilage matrix calcification. Arthritis Rheum (2001) 1.29
Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8 ORF50 gene product contains a potent C-terminal activation domain which activates gene expression via a specific target sequence. Arch Virol (2001) 1.29
The osteoprotegerin/receptor activator of nuclear factor kappaB/receptor activator of nuclear factor kappaB ligand system in cartilage. Arthritis Rheum (2001) 1.28
Inflammatory microcrystals stimulate interleukin-6 production and secretion by human monocytes and synoviocytes. Arthritis Rheum (1989) 1.28
Age- and site-associated biomechanical weakening of human articular cartilage of the femoral condyle. Osteoarthritis Cartilage (2007) 1.27
Inducible nitric oxide synthase from human articular chondrocytes: cDNA cloning and analysis of mRNA expression. Biochim Biophys Acta (1994) 1.27
Growth factor responsiveness of human articular chondrocytes in aging and development. Arthritis Rheum (1995) 1.27
Subchondral bone of the human knee joint in aging and osteoarthritis. Osteoarthritis Cartilage (2002) 1.26
N-acetylglucosamine prevents IL-1 beta-mediated activation of human chondrocytes. J Immunol (2001) 1.25
Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans. J Immunol (1986) 1.22
TSG-6: a TNF-, IL-1-, and LPS-inducible secreted glycoprotein associated with arthritis. J Immunol (1993) 1.21
Monocyte chemoattractant protein-1 (MCP-1) expression in human articular cartilage. Induction by peptide regulatory factors and differential effects of dexamethasone and retinoic acid. J Clin Invest (1992) 1.20
A DnaK homolog in Myxococcus xanthus is involved in social motility and fruiting body formation. J Bacteriol (1998) 1.20
Interleukin-11, an inducible cytokine in human articular chondrocytes and synoviocytes, stimulates the production of the tissue inhibitor of metalloproteinases. J Biol Chem (1993) 1.20
Differential effects of aging on human chondrocyte responses to transforming growth factor beta: increased pyrophosphate production and decreased cell proliferation. Arthritis Rheum (1997) 1.19
Effect of hyaluronan on chondrocyte apoptosis and nitric oxide production in experimentally induced osteoarthritis. J Rheumatol (2000) 1.19
Bacteroides fragilis toxin 2 damages human colonic mucosa in vitro. Gut (1999) 1.18
Transforming growth factor-beta and suppression of humoral immune responses in HIV infection. J Clin Invest (1991) 1.18
Development and regulation of osteophyte formation during experimental osteoarthritis. Osteoarthritis Cartilage (2002) 1.18
Regulation of cyclooxygenase-2 expression in normal human articular chondrocytes. J Immunol (1995) 1.17
Roles of cyclins A and E in induction of centrosome amplification in p53-compromised cells. Oncogene (2008) 1.16
Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. J Clin Invest (2000) 1.15
IL-6 production by human T lymphocytes. Expression in HTLV-1-infected but not in normal T cells. J Immunol (1991) 1.14
Monocyte deactivation by interleukin 10 via inhibition of tyrosine kinase activity and the Ras signaling pathway. Proc Natl Acad Sci U S A (1994) 1.14
Autoantibody production by severe combined immunodeficient mice reconstituted with synovial cells from rheumatoid arthritis patients. Eur J Immunol (1990) 1.14
Potent toxicity of 2-chlorodeoxyadenosine toward human monocytes in vitro and in vivo. A novel approach to immunosuppressive therapy. J Clin Invest (1990) 1.14
Pannocytes: distinctive cells found in rheumatoid arthritis articular cartilage erosions. Am J Pathol (1997) 1.13
Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum (1997) 1.13
Human endothelial cells produce IL-6. Lack of responses to exogenous IL-6. Ann N Y Acad Sci (1989) 1.12
Interleukin-1 induces pro-mineralizing activity of cartilage tissue transglutaminase and factor XIIIa. Am J Pathol (2001) 1.12
Cytoplasmic localization of the interferon-inducible protein that is encoded by the AIM2 (absent in melanoma) gene from the 200-gene family. FEBS Lett (2000) 1.12
Proliferating cell nuclear antigen (PCNA)/cyclin in activated human T lymphocytes. J Immunol (1987) 1.11
Effect of interleukin 17 on proteoglycan degradation in murine knee joints. Ann Rheum Dis (2000) 1.10
Studies in pseudohypoparathyroidism. Two new cases with a probable selective deficiency of thyrotropin. Am J Med (1969) 1.10
Systemic immunological effects of cytokine genes injected into skeletal muscle. Proc Natl Acad Sci U S A (1993) 1.10
Differentiation-dependent effects of IL-1 and TGF-beta on human articular chondrocyte proliferation are related to inducible nitric oxide synthase expression. J Immunol (1995) 1.10
Effects of substance P on human colonic mucosa in vitro. Am J Physiol (1999) 1.09
Anadamide, an endogenous cannabinoid receptor agonist inhibits lymphocyte proliferation and induces apoptosis. J Neuroimmunol (1994) 1.08
Biomechanical regulation of matrix metalloproteinase-9 in cultured chondrocytes. J Orthop Res (2000) 1.08
D-penicillamine therapy in cystinuria. J Urol (1966) 1.07
Nicotine-induced modulation of T Cell function. Implications for inflammation and infection. Adv Exp Med Biol (1998) 1.07
The inducible production of nitric oxide by articular cell types. Osteoarthritis Cartilage (1994) 1.07
Epstein Barr virus/complement C3d receptor is an interferon alpha receptor. EMBO J (1991) 1.06
Glucocorticoids induce Kaposi's sarcoma cell proliferation through the regulation of transforming growth factor-beta. Blood (1997) 1.06
Modulation of disease activity in murine systemic lupus erythematosus by cytokine gene delivery. Lupus (1995) 1.04
Integrin expression by human articular chondrocytes. Arthritis Rheum (1994) 1.03
ILA, a member of the human nerve growth factor/tumor necrosis factor receptor family, regulates T-lymphocyte proliferation and survival. Blood (1996) 1.02
Hyaluronan suppressed nitric oxide production in the meniscus and synovium of rabbit osteoarthritis model. J Orthop Res (2001) 1.00
Expression of the p16 and p15 cyclin-dependent kinase inhibitors in lymphocyte activation and neuronal differentiation. Cancer Res (1995) 1.00
Nitric oxide production and apoptosis in cells of the meniscus during experimental osteoarthritis. Arthritis Rheum (1999) 1.00
IL-1-induced nitric oxide inhibits chondrocyte proliferation via PGE2. Exp Cell Res (1995) 1.00
New Agent in the Treatment of Cystinuria: N-acetyl-D-penicillamine. Br Med J (1968) 1.00
Regulation of epithelial transport and barrier function by distinct protein kinase C isoforms. Am J Physiol Cell Physiol (2001) 0.99
Effect of nicotine on the immune system: possible regulation of immune responses by central and peripheral mechanisms. Psychoneuroendocrinology (1998) 0.99
Regulation of CD95 (Fas/APO-1)-induced apoptosis in human chondrocytes. Arthritis Rheum (2001) 0.98
Tumor-suppressive effects of neutral endopeptidase in androgen-independent prostate cancer cells. Clin Cancer Res (2001) 0.98
Regulation of YKL-40 production by human articular chondrocytes. Arthritis Rheum (2001) 0.97
Differential expression of TGF beta isoforms by human articular chondrocytes in response to growth factors. J Cell Physiol (1992) 0.96
A receptor induced by lymphocyte activation (ILA): a new member of the human nerve-growth-factor/tumor-necrosis-factor receptor family. Gene (1993) 0.95
Neural precursor cells possess multiple p53-dependent apoptotic pathways. Cell Death Differ (2006) 0.95
Chemotaxis in Borrelia burgdorferi. J Bacteriol (1998) 0.94